What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment.

Sven van Egmond Esther de VriesLoes HollesteinMaarten BastiaensKees-Peter de RoosDaniëlle KuijpersEwout Willem SteyerbergMarlies WakkeeKlara MosterdTamar NijstenEsther W de Bekker-Grob

Published in: PloS one (2021)

This discrete choice experiment revealed a feasible strategy to substantially reduce costs, while maintaining quality of care, based on the preferences and needs of BCC patients, which is supported by dermatologists.

Keyphrases

end stage renal disease
newly diagnosed
healthcare
chronic kidney disease
palliative care
prognostic factors
basal cell carcinoma
patient reported outcomes
single cell
health insurance
patient reported